Clinical Trial Update: The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing [Phase 4]

View source ↗

Summary

This Phase 4 trial update examines the incidence of hypoglycemia in diabetes patients treated with insulin glargine who switch dosing from bedtime to morning. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine) (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED